Introduction
29 Antiretroviral therapy (ART) limits HIV replication in previously uninfected cells leading to elimination of 30 most infected CD4+ T cells. 1 Yet, some infected cells persist and are cleared from the body at an 31 extremely slow rate despite decades of treatment. 2, 3 There is debate whether infection remains due to 32
HIV replication within a small population of cells 4,5 or due to persistence of memory CD4+ T cells with 33
HIV integrated into human chromosomal DNA. 3,6,7 If the latter mechanism predominates, prolonged 34 cellular lifespan and/or frequent cellular proliferation may sustain stable numbers of infected cells. 35 36 To optimize HIV cure strategies, mechanisms sustaining infection must be understood. Persistent viral 37 replication in a "sanctuary" where ART levels are inadequate implies a need to improve ART delivery. 8 If 38
HIV persists without replication as a latent reservoir of memory CD4+ T cells, then the survival 39 mechanisms of these cells are ideal therapeutic targets. Infected cell longevity might be addressed by 40 reactivating the lytic HIV replication cycle 9 and strengthening the anti-HIV cytolytic immune response, 41 leading to premature cellular demise. Anti-proliferative therapies could limit homeostatic or antigen 42 driven proliferation. 10-12 43 44
These competing hypotheses have been studied by analyzing HIV evolutionary dynamics. Due to the 45 high mutation rate of HIV reverse transcriptase and the large viral population size, 13 HIV replication in 46 the absence of ART produces large viral diversity. [13] [14] [15] Over time, new strains become dominant due to 47 continuous positive immunologic selection pressure against the virus. Repeated "selective sweeps" 48 cause genetic divergence, or a positive molecular evolution rate, 16 often measured by continual growth 49 in genetic distance between the consensus strain and the founder virus. 17-19 50 51
A recent study documented new HIV mutants during months 0-6 of ART in three participants at a rate 52 equivalent to pre-ART time points. New mutations were noted across multiple anatomic compartments, 53
implying widespread circulation of evolving strains. 4 One possible explanation for this data is the 54 presence of a drug sanctuary in which ART levels are insufficient to stop new infection events. 55 Alternative proposed interpretations are experimental error related to PCR resampling, or variable 56 cellular age structure within the phylogenetic trees. 20,21 57 58
In other studies of participants on more prolonged ART (at least one year), viral evolution was not 59 observed despite sampling of multiple anatomic compartments. [22] [23] [24] [25] Identical HIV DNA sequences were 60 noted in samples obtained years apart, 14, 26, 27 suggesting long-lived latently infected cells as a possible 61 mechanism of HIV persistence. 3,6,7,24,25 Clonal expansions of identical HIV DNA sequences were also 62 observed, demonstrating that cellular proliferation generates new infected cells. 4,12,24,28-30 Multiple, 63 equivalent sequences were noted in blood, gut-associated lymphoid tissue (GALT), and lymph nodes, 64 even during the first month of ART. 24,29,30 65 66
The majority of these studies relied on sequencing single genes including env, gag and pol: this approach 67 may overestimate HIV clonality because mutations in other genome segments could go unobserved. 17,31 68
In addition, these studies also measured total HIV DNA. However, a majority of HIV DNA sequences have 69 incurred deleterious mutations and do not constitute the true replication competent HIV reservoir. 32,33 70
To address these issues, a more recent study utilized a comprehensive, whole-genome sequencing 71 approach to confirm the presence of abundant replication competent sequence clones. 34 In a separate 72 cohort of patients, rebounding HIV sequences arose from replication competent clonal populations. 35 73 74
Another approach to define HIV clonality involves sequencing of the HIV integration site within human 75 chromosomal DNA. [36] [37] [38] [39] [40] While HIV tends to integrate into the same genes, 39,41 it is extremely unlikely that 76 two cellular infection events would result in HIV integration within precisely the same human 77 chromosomal locus by chance alone. 37 Thus, integration site analyses abrogate the challenge of 78 overestimating clonality due to incomplete sequencing and provide an elegant surrogate for whole 79 genome sequencing. Previous studies of integration sites found significant numbers of repeated 80 integration sites, providing strong evidence that these infected cells arose from cellular proliferation. 42,43 81
These studies are not absolutely conclusive for HIV persistence because integration site sequencing 82 cannot confirm or deny replication competency of the integrated virus. 39 83 84
While HIV sequence clonality has been widely observed, existing studies observed equivalent sequences 85 in a minority (<50%) of observed sequences. Here, we demonstrate that this finding can be explained by 86 incomplete sampling. Using tools adapted from ecology and data from two integration site studies 36,37 87 and a replication competent HIV DNA study, 34 we show that nearly all observed unique sequences are 88 likely to be members of clonal populations which derived from cellular proliferation. We predict that the 89 HIV reservoir consists of a small number of massive clones, and a massive number of small clones. 90 91
Based on these results, we used a mechanistic mathematical model to reconcile apparent evolution 92 during the early months of ART with apparent clonality after a year or more of ART. The model includes might be extrapolated to the smaller replication competent reservoir. 33 We use total HIV DNA as it  140  allows a greater sample size for analysis.  141  142  Clonal HIV DNA sequences and clonal replication competent sequences are detectable at various time  143 points during ART. To examine the structure of clonal total and replication competent HIV DNA, we 144 ranked observed sequences from several studies according to their abundance: rank-abundance curves 145 are ordered histograms denoted ( ) such that (1) is the abundance of the largest clone. These curves 146 facilitate identification of quantities of interest like the richness = max ( ), sample size = ∑ ( 36 In these studies, 1-16% (mean: 7%) of sequences were members of 174 observed sequence clones (Fig 2A) , 36, 37 meaning that HIV DNA was identified in the same chromosomal 175
integration site in at least two cells. The absolute number of observed sequence clones 78/ in the 17 176 samples ranged from 1-150 (mean: 15). The remaining sequences were identified in a specific 177 chromosomal integration site in only one cell (observed singletons). 37 For total HIV DNA, at each 178 participant time point, certain sequences predominated: the largest observed sequence clone contained 179 2-62 sequences (mean: 11), accounting for 3-26% (mean= 9%) of total observed sequences. 180 181
Hosmane et al. sequenced replication competent HIV isolates from 12 study participants on ART: 0-28% 182 (mean: 11%) of sequences were members of observed sequence clones (Fig 2B) . 34 The lack of detected 183 clones in 3 participants may reflect their low sequence sample size. Participants with fewer than 20 184 total sequences were therefore excluded from individual analyses described below but were included 185 for population level evaluations. For replication competent HIV DNA in the 5 persons having sequence 186
sample-size > 20, certain sequences dominated: the largest observed sequence clone contained 3-9 187 sequences (mean: 6.8), accounting for 11-42% (mean= 28%) of total observed sequences. The number 188 of non-singleton sequence clones 78/ in the 5 samples ranged from 1-7 (mean: 3.8).
190
Sequence sampling depth is low relative to total population size. There was a higher number of 191 experimentally detected sequences ( ) for total HIV DNA (Fig 2C) than for replication competent HIV 192 (Fig 2D) . For total HIV DNA, the number of observed unique sequences ( 9:; or the observed sequence 193 richness) was always less than ( Fig 2C) due to clonal populations. Where > 20 for replication 194 competent viruses, 9:; was always less than , again due to the presence of clones ( Fig 2D) . There was 195 a higher 9:; as the sequence sample size increased (Fig 2C&D) , suggesting that detection of unique 196
clones increases with deeper sampling. 197 198
Thus, we can infer that further sampling would likely uncover new unique sequences. To quantify the 199 relationship between sample size and discovery, we generated sample rarefaction curves (see Methods  200 and Supplementary Methods) using the rank-abundance distributions (Fig 2E&F) . These curves 201
interpolate the data to demonstrate the likely discovery of new sequences as sampling increases up to 202 the sample size of the original experiment. At low sample size, a new sequence is likely to be found with 203 each additional sample. As sampling increases, the chance of sampling a previously documented 204 sequence increases, and the slope of the rarefaction curve begins to flatten. As sample size approaches 205 the true richness of the population, the curve plateaus and few new unique sequences remain to be 206 sampled. Current sampling depth remains on the steep, initial portion of the curve. 207 208
Ecological estimates of lower bounds on true HIV sequence richness from limited samples. To estimate 209 a lower bound for true sequence richness, we used the Chao1 estimator, a nonparametric ecologic tool 210 that uses frequency ratios of observed singletons / and doubletons < (see Methods and 211
Supplementary Methods). 45, 46 For the HIV reservoir, theoretical values for true richness range from one 212 (if all sequences were identical and originated from a single proliferative cell) to the total population size 213
(if all sequences were distinct and originated from error-prone viral replication). We found estimated 214 lower bounds for true sequence richness exceeded observed richness, typically by an order of 215 magnitude in both total HIV DNA and replication competent HIV (Fig 3) . These initial lower bound 216 estimates for sequence richness are far lower than previously estimated population sizes for HIV DNA 217 and replication competent HIV DNA sequences, 2,3,6 suggesting that clones may predominate. Based on the observation that observed data was roughly log-log-linear (Figure 2A ), we chose a power-237 law model for rank-abundance: ( ) ∝ >? . Other functional forms were explored (exponential, linear, 238 and biphasic power law) but were worse or equivalent for data fitting (not shown). Our model requires 3 239 parameters, the power law exponent ( ), the sequence population size ( ), and the sequence richness 240 ( ). Model fitting is described in the Methods with additional detail in the Supplementary Methods. 241
Briefly, we generated 2,500 possible models for each data set, choosing a plausible fixed population size 242 from available data ( = 10 B for HIV DNA and = 10 C for intact, replication competent HIV 243 DNA). 2,3,6,33, 47 We then recapitulated the experiment by taking random samples from each model 244 distribution and comparing sampled data to experimental data to find optimal model parameters. This 245 resampling method correctly inferred the power law exponent from simulated power law data 246
( Supplementary Fig 1) . 247 248
However, for experimental data we could not precisely identify . Recognizing this uncertainty, we 249 developed an integral approximation to estimate the largest possible richness (least clonality) given 250 and the best-fit (derivation in Supplementary Methods and illustration in Supplementary Fig 2) . Then, 251
using the lower bound estimate from the Chao1 estimator, we were able to fully constrain the estimate 252 of true HIV sequence richness in the reservoir. Our maximal estimates for sequence richness were 253 notably several orders of magnitudes higher than Chao1 estimates (Fig 3) but lower than the total 254 sequence population size ( ). 255 256
Our method demonstrated excellent fit to cumulative proportional abundances of observed clones for 257 total HIV DNA ( Fig 4A) and replication competent HIV DNA (Fig 5A) . For total HIV DNA ( Fig 4B) and 258 replication competent HIV DNA (Fig 5B) , optimal fit was noted within narrow ranges for the power law 259 slope parameter but across a wide possible range of true sequence richness. Using the top 5 best fit 260 models, we generated extrapolated distributions of the entire HIV sequence rank-abundance for each 261 participant time point. We observed similar estimates for the population size of the largest clones, 262
which account for approximately 50% of the reservoir (200-2,000 clones for HIV DNA in Fig 4C and 2-7 263 clones for replication competent HIV DNA in Fig 5C) . However, the tail of the reservoir, which consists of 264 thousands of smaller clones, varied considerably across the parameter sets with 900-100,000 possible 265 clones accounting for 90% of the HIV DNA and 100-2,000 possible clones accounting for 90% of 266 replication competent HIV. This variability reflects the fact that true sequence richness is only partially 267 identifiable using our procedure. 268 269 distribution function to the entire pool of 10 9 infected cells for all participant time points in Fig 2A; we 288 assume the maximum possible sequence richness in each case and still note a predominance of sequence 289
clones. F. Extrapolations of the best-fit power law to the entire pool of 10 9 infected cell for all 290 participants in Fig 2A; the top 1,000 clones each consist of >10 4 cells each. A large number of clones 291 (~10 6 ) contain many fewer cells (<100). 292 293
Even under the most conservative assumptions (maximum possible true sequence richness in Fig 3) , the 294 vast majority of sequences were predicted to be members of true sequence clones. For the participant 295
in Fig 4C, a maximum of 200,000 clones were needed to reach 100% cumulative abundance for HIV DNA. 296
The ratio of estimated true sequence richness to the total number of infected cells / with HIV DNA 297 (~10 5 : 10 9 ) represents an upper limit on the fraction of sequences that are true singletons: we estimate 298 that greater than 99.9% of infected cells contain true clonal sequences (Fig 3) . 299 300
Similarly, the ratio of estimated true sequence richness to the total number of infected cells with 301 replication competent HIV for the participant in Fig 5C was 10 5 :10 7 . Hence, at least 99% of cells contain 302 true clonal sequences (Fig 3) . Of note, this ratio is stable regardless of assumed reservoir size. For 303 instance, if we assume a true reservoir size of 10 6 , then our estimate of true sequence richness is ~10 4 . 304 305
The model fitting procedure was used on all data in Fig 2. We biased against a clonally dominated 306 reservoir to the greatest extent possible by selecting the best fitting power law exponent and then 307 calculating the maximum possible sequence richness (Fig 3) . The power law slope parameter was on 308 average lower across participants for HIV DNA ( = 0.9 ± 0.1) than for replication competent HIV DNA 309 ( = 1.4 ± 0.2). As a result, the predicted cumulative distribution of HIV DNA (Fig 4E) was often 310
concave-up with log rank as compared to concave-down with log rank noted for replication competent 311
HIV DNA (Fig 5E) , suggesting that a smaller number of extremely large clones might make up a higher 312
proportion of the replication competent HIV reservoir. 313 314
For both HIV DNA (Fig 4F) and replication competent virus (Fig 5F) , the top 100 clones in all participants 315 are estimated to be massive (>10 5 and >10 4 cells respectively). However, there are also large numbers of 316 much smaller clones with fewer than 1,000 cells (>10 6 and >10 4 clones respectively). In contrast to 317 observed data, a majority of sequences are clonal, suggesting that proliferation is the major generative 318 mechanism of persistent HIV-infected cells. 319
Figure 5. Ecologic modeling suggests a majority of replication competent HIV sequences are members 321
of sequence clones. To recapitulate experimental conditions in Fig 2B, Fig 2B) ; we 337 assume the largest possible observed sequence richness in each case and still note a predominance of 338 sequence clones. F. Extrapolations of the best-fit power law to the entire pool of 10 7 infected cell for all 339 participants in Fig 2B; the top 100 clones again consist of >10 4 cells each. A large number of clones 340 (~10 4 ) contain many fewer cells (<100). 341 342
Modeling combined population data gives similar results as individual fitting. To increase sample size 343 and eliminate bias related to excluding participants with low sample sizes, we combined results from all 344 participant time points for HIV DNA (17 time points) and replication competent HIV (12 time points) into 345 single rank order distribution curves. We then fit the power law models to both sets of data 346 (Supplementary Fig 3A&B, E&F) . We again noted a narrow range of possible values for the power law 347 exponent and a large range of possible values for true sequence richness. The exponent was again < 348 1 for total HIV DNA and ≈ 1 for replication competent virus (Supplementary Fig 3A&E) , leading to 349 concave-up and linear relationships between cumulative proportional abundance and log rank, 350
respectively (Supplementary Fig 3C&G) . We estimated that at least 99.9% of cells with HIV DNA 351
( Supplementary Fig 3C) and 99.8% of cells with replication competent HIV (Supplementary Fig 3G) 
352
contain true clonal sequences. The top 100 HIV DNA clones ( Supplementary Fig 3D) and replication 353 competent clones (Supplementary Fig 3H) contained >10 6 and >10 4 cells respectively. 354 355
Using the population level data, we generated sample rarefaction curves from the extrapolated rank-356 abundance curves. These curves show that after 10,000 sequences were sampled, the observed 357 sequence richness would continue to increase with more sampling (Supplementary Fig 4) . Even if 358 experimental sample sizes could be increased 100-fold from the present data, sequences would 359 continue to be dominated by those from large clones. Our statistical inference approach is therefore 360 necessary to provide a more realistic estimate of the clonal distribution of the HIV reservoir. 361 362
A mechanistic model that includes both an ART sanctuary and cellular proliferation can reconcile 363 observations from early and late ART. Our analyses above identify the critical role of cellular 364 proliferation in generating infected cells after a year of ART but do not capture the dynamic mechanisms 365 underlying this observation or explain possible evidence of viral evolution during months 0-6 of ART. 4 366
We therefore developed a viral dynamic mathematical model. Our model (Fig 6A) consists of differential 367 equations, described in detail in the Methods. Most model parameter values are obtained from the 368 literature (Table 1) . 369 371  produced by the sanctuary and virus produced by a reactivating reservoir up until months 4-6 sanctuary size must also be limited (0.001-0.01% of the original burden of replicating HIV) to achieve 403 realistic viral decay kinetics. 51 In the absence of contradictory information, we assumed homogeneous 404 mixing of / and O in blood and lymph nodes. 4 405 406
Figure 6. A mechanistic model recapitulates HIV RNA decay and predicts rough equivalence of virus
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Based on the observation that activated, uninfected CD4+ T cells (S), the targets for replicating HIV, 407 decrease in numbers after initiation of ART we also simulate the model with and without the possibility 408 of slow target cell decline within the HIV drug sanctuary. We approximate this process with an 409 exponential decay of target cells with rate (per day). 52,53 The decay rate is lower than concurrent decay 410 rates measured from HIV RNA 50,51,54 because abnormal T cell activation persists for more than a year 411 after ART. 53 412 413
The model accurately simulates viral dynamics during ART. We fit the model to ultra-sensitive viral load 414 measurements collected from multiple participants in Palmer et al. 51 We included experimentally 415 derived values for most parameter values (Table 1) , solving only for activation rates < and L by fitting 416 to viral load. Simulations reproduce three phases of viral clearance (Fig 6B) and predict trajectories of 417 infected cell compartments (Fig 6C) . Of note, the model is able to achieve fit to the data with different 418 assumptions of starting values of the three infected cell compartments (the relative proportion of which 419 are unknown pre-ART): in this circumstance, we arrive at different values of < and L without impacting 420 overall model conclusions regarding the HIV reservoir. The size of the sanctuary (expressed as the 421 fraction of infected cells O ) is only constrained to be below a value <10 -5 to ensure accurate model fit 422
for a static sanctuary model. 423 424
Cellular proliferation sustains HIV infection during ART whether or not a small drug sanctuary exists. 425 We next used the model to estimate the fraction of cells generated by cellular proliferation versus viral 426 replication. We conservatively assumed that prior to ART all infected cells were generated by viral 427
replication. Then, we tracked the number of cells whose origin was replication and the number whose 428 origin was cellular proliferation. Without directly simulating a phylogeny, the fraction of all cells that 429 derive from replication provides a surrogate for the expected fraction of cells that would give a signal of 430 evolution. We also distinguish the current replication percentage, the fraction of infected cells currently 431 being generated from viral replication, from the net replication percentage, the fraction of total infected 432 CD4+ T cells at a given time whose origin was HIV replication. This distinction allows us to contrast the 433 net number of surviving, historically-infected cells with the number of cells that are presently being 434 generated via HIV infection. Because many long-lived cells were once generated by HIV infection, the 435 net replication percentage may exceed the current replication percentage. 436 437
We then simulated the model under several plausible sanctuary and reservoir conditions to assess the 438 relative contributions of infection and cellular proliferation in sustaining infected cells. We considered 439 different reservoir compositions based on evidence that effector memory (Tem), central memory (Tcm)  440 and naïve (Tn) cells proliferate at different rates and that distributions of infection in these cells differ 441 among infected patients. 12,42,43 Further, because a drug sanctuary has not been observed, its true 442 volume is unknown and may vary across persons. We therefore conducted simulations with a static 443 sanctuary, a slowly diminishing sanctuary, and no drug sanctuary (Fig 7A) . 444 445 446
Figure 7. The vast majority of infected cells are generated via proliferation within 6 months of ART 447
initiation. Model simulations contrast the number of cells generated by viral replication with those 448 generated by cellular proliferation. The fraction of cells generated by replication at any time point is 449
referred to as the current replication percentage. The fraction of cells that remain alive whose ultimate 450
origin was viral replication is referred to as the net replication percentage. Different assumptions 451 regarding sanctuary ( O ) and latent cell populations ( L ) were simulated corresponding to columns. A. 452
Moving left to right, we assume a static drug sanctuary, a slowly declining drug sanctuary and no drug 453
sanctuary
. Pie charts on the right indicate the reservoir composition by T cell phenotypes and correspond 454 with colored lines in B-D. B. Under all assumptions, once ART is initiated, most new infected cells arise 455
due to cellular proliferation as opposed to HIV replication after 12 months of ART. C. New latently 456
infected reservoir cells ( L ) are generated almost entirely by proliferation soon after ART is initiated 457 under all conditions. D. The observed proportion of infected cells originally generated by HIV infection 458 rather than cellular proliferation will overestimate the actual ongoing proportion during the first 6 459 months of ART assuming a small or large sanctuary volume. This trend is more notable when the 460 reservoir contains a higher proportion of slowly proliferating naïve T cells. 461 462
Regardless of assumed pre-treatment reservoir composition and sanctuary size, the contribution of 463 replication to generation of new infected cells is negligible after one year of ART. The contribution of 464 new replication diminishes rapidly with time on ART regardless of whether a sanctuary is assumed (Fig  465  7B) . The fraction of long lived latently infected cells ( L ) generated by viral replication (Fig 7C, note log  466 scale) is negligible within days of ART initiation. This finding captures the extent of the impact of 467 proliferation even when a sanctuary is assumed. 468 469
Observable HIV DNA sequence evolution during early ART can represent a fossil record of prior 470 replication events. In all simulations, the net fraction of cells generated from viral replication rather 471 than cellular proliferation at 6 months of ART (5-25% in Fig 7D) is higher than the current percentage 472 generated by replication (Fig 7B) . A higher fraction of slowly proliferating Tn cells exacerbates the 473 difference between historical and contemporaneous generation of infected cells (Fig 7D, green line) . 474
Because the net fraction is what will be observed experimentally, the model reveals why ongoing 475 evolution might be observed even while the dominant mechanism sustaining the reservoir is cellular 476
proliferation. In keeping with the first section of our paper, after 12 months of ART, the net and current 477 percentage of infected cells generated by HIV replication become negligible for all simulated parameter 478 sets. Importantly, the lag between net and current viral replication generation emerges whether or not 479 a small drug sanctuary is included in the model. 480 481 We refer to the phenomenon that long-lived cells may contain signatures of past viral replication as the 482 "fossil record". To emphasize the concept, the fossil record finding is qualitatively illustrated in infected cells, the proportion of infected cells that were once generated by HIV replication (the net 492 replication percentage, or "fossil record" of HIV replication) remains >30% for the first 2 months of ART. 493
However, in this time, the proportion of cells newly generated by HIV replication (shaded box) becomes 494
negligible. The net fraction is observed experimentally, so our simulations indicate a contemporaneous 495
representation of the HIV reservoir cannot be observed until the "fossil record" is completely washed out, 496 sometime between 6 months and a year of ART. 497 498 Different factors drive net (observed) and current replication percentage during early ART. We next 499 performed sensitivity analyses to identify parameters that impact the timing of transition from HIV 500 replication to cellular proliferation as a source for new and observed infected cells. Under all parameter 501 assumptions, the majority of new infected cells arose from proliferation after a year of chronic ART (Fig  502  9A) . Only the sanctuary decay rate ( ) had an important impact on generation of new infected cells. Our 503 analysis included a sanctuary in which target cell availability did not decay at all. In that scenario, 5-10% 504 of new infected cells were generated by HIV replication after a year of ART (Fig 9A) , which is not 505 consistent with lack of viral evolution observed at this timepoint. Rapid disappearance of HIV replication 506 as a source of new infected cells was identified regardless of initial reservoir volume, drug sanctuary 507 volume, ART efficacy, and reservoir composition (fraction of Tem, Tcm, and Tn). 508 509
The net replication percentage was completely unaffected by the decay rate of target cells within the 510 drug sanctuary. Only an increase in the percentage of slowly proliferating reservoir cells (Tn) predicted 511 an increase in the net replication percentage (Fig 9A) . The drivers of current infected cell and net 512 infected cell origin therefore differed completely, highlighting the major differences between observed 513 sequence data and contemporaneous mechanisms generating new infected cells. 514 515 To confirm these results, we simulated 10 4 possible patients in a global sensitivity analysis in which all 534 parameter values were simultaneously varied. A rapid transition to proliferation as the source of new 535 infected cells occurred during year one of ART in a majority of simulated patients, and the same 536 variables correlated significantly with net and current replication percentage, respectively (Fig 9B&C) . 537 Overall, this analysis does not rule out the possibility of a drug sanctuary but does confirm that its 538
Figure 9. Transition from replication to proliferation as the dominant mechanism of HIV persistence
relative impact compared to cellular proliferation is likely to be minimal. 539
Discussion

540
To eliminate HIV infected cells during prolonged ART, it is necessary to understand the mechanisms by 541 which they persist. In this paper, we used existing data and two methods -inference of HIV clone 542 distributions and mechanistic mathematical modeling -to determine that a majority of infected cell 543 persistence is due to cellular proliferation rather than HIV replication. These conclusions suggest 544 strategies that enhance ART delivery to anatomic drug sanctuaries are less likely to be effective at 545 In the first part of the paper, we used existing data to infer the true clonal distributions within the entire 549 reservoir of HIV sequences in infected participants on long term ART. While the raw data indicate 550 substantial fractions of observed singleton sequences, when the total reservoir size is considered, these 551 observed singletons are revealed to be predominately members of clonal populations. In fact, the HIV 552 reservoir appears to be defined by a rank-abundance distribution of clone sizes that can be roughly 553 approximated as a power-law relationship. This distribution implies that a small number of massive 554 clones, and a massive number of small clones, comprise a large percentage of sequences. 555 556
A power-law distribution can be created when a heterogeneous population grows multiplicatively with a 557 widely variable growth rate. 55 This suggests that the distribution of clone sizes in the reservoir is likely to 558 have a mechanistic basis. It is plausible, though unproven, that such variable growth arises from rapid 559 bursts of CD4+ T cell proliferation due to cognate antigen recognition. HIV integration into tumor 560 suppression genes could also account for some observed clonal dominance. 36, 37 Smaller clones may arise 561 from homeostatic proliferation, or less frequent exposure to smaller amounts of cognate antigen. 562 563
Another consequence of our inference is that we can more precisely define the mechanism sustaining 564 equivalent sequences observed in longitudinal samples separated by many years. While we cannot rule 565 out cellular longevity as a cause of HIV persistence in certain cells, the observation of multiple clonal 566 sequences could not arise from purely long-lived latently infected cells. In fact, our analysis suggests that 567 most observed singlet sequences arise from resampling clonal populations that have undergone many 568 rounds of proliferation. 569 570
The first analysis does not include time-dynamics in the reservoir. Consequently, in the second part of 571 the paper we develop a mechanistic model to reconcile observations from early and late ART. This 572 model is the first to include the three main mechanistic hypotheses for reservoir persistence: an ART 573 sanctuary, long-lived latent cells, and proliferation of latent cells. The model recapitulates known HIV 574 RNA decay kinetics while tracking cells that originate from ongoing replication and cellular proliferation. 575 576
The model helps to explain how a "fossil record" of evolution would be observed early during ART, 577 whether or not a small drug sanctuary exists. The model tracks both the fraction of cells that were 578 generated by viral replication at a given time (current replication percentage) and the fraction that were 579 generated by viral replication at any time point but are "fossilized" in a long-lived latently infected state 580 (net, or observed, replication percentage). The net replication percentage remains non-negligible in the 581 first months of ART even while the current replication percentage drops rapidly. Thus, an observed 582 sequence that was once created by viral replication (and thus might give a signal of divergence from the 583 founder virus) can represent a historic replication event rather than current replication. Because time of 584 detection does not correlate linearly with sequence age, inference of evolution early during ART is 585 problematic. 20,21 However, the fossil record is transient: within a year of effective ART, observed 586 phylogenetic data is more likely to represent true reservoir dynamics. Our model agrees with 587 observations reflecting a lack of contemporaneous HIV evolution after this time. 14,22-27,29,30,36,37 588 589
Our sensitivity analysis shows that the major variable correlating with higher observed replication 590 percentages (a larger proportion of slowly proliferating CD4+ T cells in the reservoir) is not the same 591 variable that correlates with higher new replication percentages (a slower decrease in sanctuary size). 592
Replication percentage correlates with the amount of ongoing evolution in viral populations. Without 593 requiring any phylogenetic simulation, this simple model provides an explanation for evolution during 
